Artelo Biosciences Stock Quote ARTL - Stock Price, News, Charts, Message Board, Trades

Professional-Grade Tools, for Individual Investors.

Premium

Current Price

1.3346

Bid

1.30

Ask

1.45

Volume

16,967

1.36 Day's Range 1.43

1.15 52 Week Range 2.98

Market Cap

4.68M

Previous Close

1.45

Open

1.42

Last Trade

1.36

Last Trade Time

Financial Volume

$ 23,548

VWAP

1.3879

Average Volume (3m)

90,977

Shares Outstanding

3,227,700

Dividend Yield

PE Ratio

-0.50

Earnings Per Share (EPS)

-2.88

Revenue

Net Profit

-9.29M

Artelo Biosciences Inc is a United States based development-stage biopharmaceutical company. It is focused on discovering, licensing, developing and commercializing treatments that control the endocannabinoid system. The company seeks to pursue technologies and programs that offer proprietary approa... Artelo Biosciences Inc is a United States based development-stage biopharmaceutical company. It is focused on discovering, licensing, developing and commercializing treatments that control the endocannabinoid system. The company seeks to pursue technologies and programs that offer proprietary approaches to cannabinoid-based therapies, including those derived from the cannabis plant and synthetic cannabinoids, as well as new chemical entities and compounds that promote the effectiveness of the endocannabinoid system. The firm's flagship program is designed to be a patent-protected cannabinoid drug combination treatment for a rare and orphan disease. Show more

Sector

Pharmaceutical Preparations

Industry

Pharmaceutical Preparations

Website

www.artelobio.com

Headquarters

Fernley, Nevada, USA

Founded

1970

Artelo Biosciences Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker ARTL. The last closing price for Artelo Biosciences was $1.45. Over the last year, Artelo Biosciences shares have traded in a share price range of $ 1.15 to $ 2.98.

Artelo Biosciences currently has 3,227,700 shares outstanding. The market capitalization of Artelo Biosciences is $4.68 million. Artelo Biosciences has a price to earnings ratio (PE ratio) of -0.50.

Artelo Biosciences Receives FDA Clearance of its IND Application for ART26.12, a Selective Fatty Acid Binding Protein 5 Inhibitor

ART26.12 seeks to address a critical need in painful neuropathies, including chemotherapy-induced peripheral neuropathy for which there is no FDA-approved treatment Phase 1 trial results expected...

Artelo Biosciences Presents Comparative Data from Key Preclinical Studies on ART12.11 at the 34th Annual International Cannabinoid Research Society Symposium

SOLANA BEACH, Calif., July 03, 2024 (GLOBE NEWSWIRE) -- Artelo Biosciences, Inc. (Nasdaq: ARTL), a clinical-stage pharmaceutical company focused on modulating lipid-signaling pathways to develop...

Artelo Biosciences Announces Data Supporting Broad Potential Utility of its FABP Inhibitor Platform

Inhibition of FABP5 Demonstrates Activity in Cancer, Psoriasis, and Anxiety Disorders Results from Several Research Studies Presented at the Annual ICRS Symposium SOLANA BEACH, Calif., July 02...

Artelo Biosciences Presents Preclinical Data on ART26.12 in Breast Cancer-Induced Bone Pain at the 34th Annual International Cannabinoid Research Society Symposium

SOLANA BEACH, Calif., July 01, 2024 (GLOBE NEWSWIRE) -- Artelo Biosciences, Inc. (Nasdaq: ARTL), a clinical-stage pharmaceutical company focused on modulating lipid-signaling pathways to develop...

Artelo Biosciences Presents Important New Data on ART26.12 at the 57th Annual Scientific Meeting of the British Pain Society

SOLANA BEACH, Calif., June 04, 2024 (GLOBE NEWSWIRE) -- Artelo Biosciences, Inc. (Nasdaq: ARTL), a clinical-stage pharmaceutical company focused on modulating lipid-signaling pathways to develop...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	-0.0054	-0.402985074627	1.34	1.55	1.23	913643	1.32939356	CS
4	0.0646	5.08661417323	1.27	1.55	1.2205	248076	1.32906655	CS
12	0.0146	1.10606060606	1.32	1.58	1.1801	90977	1.33456717	CS
26	-0.0754	-5.3475177305	1.41	1.75	1.1801	49335	1.35924035	CS
52	-0.6254	-31.9081632653	1.96	2.98	1.15	97217	1.71728698	CS
156	0.2846	27.1047619048	1.05	7.2	0.2599	937426	1.03080526	CS
260	-1.8154	-57.6317460317	3.15	7.2	0.2599	1231156	1.40890204	CS

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
MIRAMIRA Pharmaceuticals Inc	$ 5.01 (627.35%)	151.42M
CMAXCareMax Inc	$ 5.7101 (261.40%)	100.56M
NUKKNukkleus Inc	$ 0.5415 (69.22%)	24.87M
SNOASonoma Pharmaceuticals Inc	$ 0.423 (37.34%)	4.57M
LPSNLivePerson Inc	$ 1.2999 (31.30%)	8.57M
LGCBLinkage Global Inc	$ 3.6601 (-29.82%)	168k
CGBSCrown LNG Holdings Ltd	$ 0.9997 (-29.10%)	3.39M
SPECSpectaire Holdings Inc	$ 0.3962 (-24.53%)	1.87M
GSUNGolden Sun Health Technology Group Ltd	$ 5.13 (-23.66%)	158.79k
PSNLPersonalis Inc	$ 2.9808 (-22.58%)	3.11M
NVDANVIDIA Corporation	$ 123.54 (4.76%)	239M
SQQQProShares UltraPro Short QQQ	$ 8.09 (-4.37%)	183.65M
MIRAMIRA Pharmaceuticals Inc	$ 5.01 (627.35%)	158.15M
SERVServe Robotics Inc	$ 8.73 (15.63%)	151.56M
NCPLNetcapital Inc	$ 0.1118 (7.50%)	124.37M